FertiBAY - Fertility-Preserving Surgery in Patients with Early-Stage Endometrial, Cervical, and Ovarian Cancer, as well as Atypical Endometrial Hyperplasia and Ovarian Borderline Tumors

FertiBAY - Fertility-Preserving Surgery in Patients with Early-Stage Endometrial, Cervical, and Ovarian Cancer, as well as Atypical Endometrial Hyperplasia and Ovarian Borderline Tumors - FertiBAY

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00040267

Enrollment

500

Registered

2026-05-19

Start date

2026-06-01

Completion date

Unknown

Last updated

2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C54 C53 C56 D07

Interventions

Group 1: Retrospective study of overall and recurrence-free survival, pregnancy and birth rates, and neonatal outcomes in patients who underwent fertility-preserving surgery for early-stage endometri

Eligibility

Sex/Gender

Female

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients who underwent fertility-sparing surgery for endometrial cancer (C54.-), cervical cancer (C53.-), and ovarian cancer (C56.-) Patients with borderline ovarian tumors (C56.-) Patients with atypical endometrial hyperplasia (D07.0; N85.0; N85.1; N85.9)

Exclusion criteria

Exclusion criteria: Patients younger than 18 years and patients in whom a primary fertility-sparing approach was not performed are excluded from the study cohort. As the questionnaires are administered in German, patients who are unable to read or complete them are also excluded.

Design outcomes

Primary

Measure	Time frame
The primary study endpoints are overall survival (OS), recurrence-free survival (RFS), pregnancy rates, and live birth rates. These will be assessed through patient interviews and questionnaires.	—

Secondary

Measure	Time frame
Assessment of oncologic and reproductive outcomes following fertility-sparing treatment in gynecologic malignancies and precancerous lesions, including time to pregnancy, pregnancy outcomes, timing of diagnosis in relation to pregnancy, rates of completion surgery after childbearing, and effects on quality of life and sexual function.	—

Countries

Germany

Contacts

Public ContactJulius Emons

Universitätsklinikum Erlangen - Frauenklinik

fk-fertibay@uk-erlangen.de+4991318533553

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Jun 11, 2026